These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 33373587)
1. Structural basis of γ-secretase inhibition and modulation by small molecule drugs. Yang G; Zhou R; Guo X; Yan C; Lei J; Shi Y Cell; 2021 Jan; 184(2):521-533.e14. PubMed ID: 33373587 [TBL] [Abstract][Full Text] [Related]
2. Activation of γ-Secretase Trimming Activity by Topological Changes of Transmembrane Domain 1 of Presenilin 1. Cai T; Yonaga M; Tomita T J Neurosci; 2017 Dec; 37(50):12272-12280. PubMed ID: 29118109 [TBL] [Abstract][Full Text] [Related]
3. Identification of presenilin 1-selective γ-secretase inhibitors with reconstituted γ-secretase complexes. Lee J; Song L; Terracina G; Bara T; Josien H; Asberom T; Sasikumar TK; Burnett DA; Clader J; Parker EM; Zhang L Biochemistry; 2011 Jun; 50(22):4973-80. PubMed ID: 21528914 [TBL] [Abstract][Full Text] [Related]
4. Mapping the Binding Site of BMS-708163 on γ-Secretase with Cleavable Photoprobes. Gertsik N; Am Ende CW; Geoghegan KF; Nguyen C; Mukherjee P; Mente S; Seneviratne U; Johnson DS; Li YM Cell Chem Biol; 2017 Jan; 24(1):3-8. PubMed ID: 28065657 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of γ-Secretase Leads to an Increase in Presenilin-1. Sogorb-Esteve A; García-Ayllón MS; Llansola M; Felipo V; Blennow K; Sáez-Valero J Mol Neurobiol; 2018 Jun; 55(6):5047-5058. PubMed ID: 28815510 [TBL] [Abstract][Full Text] [Related]
6. An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates. McKee TD; Loureiro RM; Dumin JA; Zarayskiy V; Tate B J Neurosci Methods; 2013 Feb; 213(1):14-21. PubMed ID: 23219895 [TBL] [Abstract][Full Text] [Related]
7. Semagacestat Is a Pseudo-Inhibitor of γ-Secretase. Tagami S; Yanagida K; Kodama TS; Takami M; Mizuta N; Oyama H; Nishitomi K; Chiu YW; Okamoto T; Ikeuchi T; Sakaguchi G; Kudo T; Matsuura Y; Fukumori A; Takeda M; Ihara Y; Okochi M Cell Rep; 2017 Oct; 21(1):259-273. PubMed ID: 28978478 [TBL] [Abstract][Full Text] [Related]
8. Potent γ-secretase inhibitors/modulators interact with amyloid-β fibrils but do not inhibit fibrillation: a high-resolution NMR study. Yesuvadian R; Krishnamoorthy J; Ramamoorthy A; Bhunia A Biochem Biophys Res Commun; 2014 May; 447(4):590-5. PubMed ID: 24747079 [TBL] [Abstract][Full Text] [Related]
9. Identification of gamma-secretase inhibitor potency determinants on presenilin. Zhao B; Yu M; Neitzel M; Marugg J; Jagodzinski J; Lee M; Hu K; Schenk D; Yednock T; Basi G J Biol Chem; 2008 Feb; 283(5):2927-38. PubMed ID: 18032377 [TBL] [Abstract][Full Text] [Related]
10. First and second generation γ-secretase modulators (GSMs) modulate amyloid-β (Aβ) peptide production through different mechanisms. Borgegard T; Juréus A; Olsson F; Rosqvist S; Sabirsh A; Rotticci D; Paulsen K; Klintenberg R; Yan H; Waldman M; Stromberg K; Nord J; Johansson J; Regner A; Parpal S; Malinowsky D; Radesater AC; Li T; Singh R; Eriksson H; Lundkvist J J Biol Chem; 2012 Apr; 287(15):11810-9. PubMed ID: 22334705 [TBL] [Abstract][Full Text] [Related]
11. Development and mechanism of γ-secretase modulators for Alzheimer's disease. Crump CJ; Johnson DS; Li YM Biochemistry; 2013 May; 52(19):3197-216. PubMed ID: 23614767 [TBL] [Abstract][Full Text] [Related]
12. Quantitative pharmacokinetic/pharmacodynamic analyses suggest that the 129/SVE mouse is a suitable preclinical pharmacology model for identifying small-molecule γ-secretase inhibitors. Lu Y; Zhang L; Nolan CE; Becker SL; Atchison K; Robshaw AE; Pustilnik LR; Osgood SM; Miller EH; Stepan AF; Subramanyam C; Efremov I; Hallgren AJ; Riddell D J Pharmacol Exp Ther; 2011 Dec; 339(3):922-34. PubMed ID: 21930801 [TBL] [Abstract][Full Text] [Related]
13. γ-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilin. Pozdnyakov N; Murrey HE; Crump CJ; Pettersson M; Ballard TE; Am Ende CW; Ahn K; Li YM; Bales KR; Johnson DS J Biol Chem; 2013 Apr; 288(14):9710-9720. PubMed ID: 23396974 [TBL] [Abstract][Full Text] [Related]
14. γ-Secretase modulator in Alzheimer's disease: shifting the end. Xia W; Wong ST; Hanlon E; Morin P J Alzheimers Dis; 2012; 31(4):685-96. PubMed ID: 22710916 [TBL] [Abstract][Full Text] [Related]
15. γ-Secretase Inhibitors and Modulators Induce Distinct Conformational Changes in the Active Sites of γ-Secretase and Signal Peptide Peptidase. Gertsik N; Chau DM; Li YM ACS Chem Biol; 2015 Aug; 10(8):1925-31. PubMed ID: 26030233 [TBL] [Abstract][Full Text] [Related]
17. Structural basis of Notch recognition by human γ-secretase. Yang G; Zhou R; Zhou Q; Guo X; Yan C; Ke M; Lei J; Shi Y Nature; 2019 Jan; 565(7738):192-197. PubMed ID: 30598546 [TBL] [Abstract][Full Text] [Related]
18. Γ-secretase modulators do not induce Aβ-rebound and accumulation of β-C-terminal fragment. Li T; Huang Y; Jin S; Ye L; Rong N; Yang X; Ding Y; Cheng Z; Zhang J; Wan Z; Harrison DC; Hussain I; Hall A; Lee DH; Lau LF; Matsuoka Y J Neurochem; 2012 Apr; 121(2):277-86. PubMed ID: 22035227 [TBL] [Abstract][Full Text] [Related]
19. Membrane Dynamics of γ-Secretase Provides a Molecular Basis for β-Amyloid Binding and Processing. Somavarapu AK; Kepp KP ACS Chem Neurosci; 2017 Nov; 8(11):2424-2436. PubMed ID: 28841371 [TBL] [Abstract][Full Text] [Related]
20. Novel gamma-secretase inhibitors uncover a common nucleotide-binding site in JAK3, SIRT2, and PS1. Wu F; Schweizer C; Rudinskiy N; Taylor DM; Kazantsev A; Luthi-Carter R; Fraering PC FASEB J; 2010 Jul; 24(7):2464-74. PubMed ID: 20237298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]